Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
Pharma News, 2025
Jade Biosciences Presents JADE101
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
Eli Lilly and Camurus enter cardiometabolic health partnership worth up to $870m
Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic health.
Finerenone plus SGLT2 inhibitor reduces albuminuria more than either drug alone
Concurrent use of finerenone and empagliflozin reduced urine albumin-to-creatinine ratio for adults with CKD and type 2 diabetes.
RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals
During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.
Ozempic linked to rare cases of serious eye disorder
Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may, in very rare cases, cause a serious eye condition that can lead to vision loss, the European Medicines Agency's sa...
AstraZeneca’s Calquence approved by EC for first-line chronic lymphocytic leukaemia use
An estimated 27,000 cases of the disease were diagnosed in the UK, France, Germany, Spain and Italy in 2024
Dyne Therapeutics to Present New Preclinical Data
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
Radiopharm Theranostics Reports Preclinical
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
Darolutamide Receives FDA Approval for mCSPC
The FDA approved darolutamide monotherapy for use in metastatic hormone-sensitive prostate cancer following ARANOTE findings.
Four States Ask F.D.A. to Lift Special Restrictions on Abortion Pill
The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety. Mifepristone, which blocks a hormone necessary for pregnancy to develop, was...
FDA phasing out animal testing in preclinical safety studies
The Food and Drug Administration (FDA) said it will reduce or replace its animal testing requirement for “more effective, human-relevant methods,” such as artificial intelligence (AI&#...
Alvotech and Advanz to commercialise biosimilars in Europe
Alvotech and UK-based Advanz Pharma have broadened their commercial collaboration with an agreement to include three additional biosimilar candidates for commercialisation in Europe.
27
28
29
30
31
32
33
34
35
